ARQT vs ISRG
Arcutis Biotherapeutics, Inc. vs Intuitive Surgical — AI-powered side-by-side comparison
ARQT
Arcutis Biotherapeutics, Inc.
70
Buy
VS
ISRG
Intuitive Surgical
60
Buy
| Metric | ARQT | ISRG |
|---|
| AI Score |
70
|
60
|
| Price |
$24.85
|
$371.73
|
| P/E Ratio |
112.23×
|
42.21×
|
| ROE |
-8.5%
|
16.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
91.1%
|
66.7%
|
| Debt / Equity |
0.52×
|
0.00×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
33.0
|
40.0
|
| Beta |
1.526
|
1.46
|
| Expected Upside |
+2.6%
|
+18.5%
|
AI Committee View
Current Innellis committee reasoning for ARQT versus ISRG.
ARQT leads by 10 points.
ARQT scores 70/100 (Buy) versus ISRG at 60/100 (Buy).
ARQT Committee View
80% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- News sentiment is positive (+0.80 across 5 articles, 14d) — News
Bear Case
- MACD histogram negative -- bearish momentum — Technical
ISRG Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 17.8% shows genuine earnings power backing the valuation — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 45.2 is expensive by classic value standards — Value
- Price-to-book of 11.3x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical